Wire · opportunities
New FDA-Cleared Test Tells Clinicians Bacterial From Viral in Minutes, Not Days
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 12 November 2026 · Fusion42 review
The FDA has cleared the Access MeMed BV assay from Beckman Coulter Diagnostics, a rapid blood test that differentiates bacterial from viral infections in adults and children, providing results in as little as 15 minutes using existing hospital analyzers. This test supports timely and appropriate treatment decisions, can reduce unnecessary antibiotic use, and lower healthcare costs by decreasing avoidable admissions and tests.
This Wire brief sits within Fusion42's coverage of Medtech, and 9 sources have reported it between 3 Nov 2026 and 12 Nov 2026.
◆ ◆ The Wire takeaway
You can now offer clinicians a test breaking the hours-to-days barrier in infection diagnosis, setting your product apart by enabling faster treatment decisions and cutting unnecessary antibiotic use. This opens a new door for Medtech firms targeting rapid infectious disease diagnostics in high-turnover clinical settings.
◆ Coverage
9 sources · first reported 3 Nov 2026 · latest 12 Nov 2026
◆ Related on Wire
◆ Topics